Unlock instant, AI-driven research and patent intelligence for your innovation.

Immune suppression fusion protein, its coded nucleic acid and application

A technology of fusion protein and toxin protein, which is applied in the field of immunology, drug design, and molecular biology, and can solve problems such as large toxic side effects, short immune tolerance period, and transplant failure

Inactive Publication Date: 2006-09-13
AFFILIATED HOSPITAL CHINA ACADEMY OF MILITARY MEDICAL SCI
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, looking at the current international research methods to explore the B7:CD28 / CTLA4 system to prevent and treat GVHD or induce immune tolerance, all of them are blocked or blocked with anti-B7 monoclonal antibody / polyclonal antibody or CTLA4-Ig.
The disadvantages are: first, whether it is the blocking or blocking of anti-B7 monoclonal antibody / polyclonal antibody or CTLA4-Ig, the period of immune tolerance induced is too short; second, only blocking the B7:CD28 / CTLA-4 system induces The immune tolerance of T cells can be reversed by the release of IL-2 and other cytokines caused by post-transplant infection and other factors, leading to transplant failure; third, the anti-B7 monoclonal antibody / polyclonal antibody used in blocking or blocking Rat-derived, highly toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immune suppression fusion protein, its coded nucleic acid and application
  • Immune suppression fusion protein, its coded nucleic acid and application
  • Immune suppression fusion protein, its coded nucleic acid and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] Example 1: Cloning of B7-2 Extracellular Region cDNA

[0096] According to the published B7-2 and B7-1 gene sequences, primers were designed to amplify the cDNA encoding B7-2 extracellular region 225aa and B7-1 extracellular region 208aa, and were verified by GOLDKEY software. The primer sequence of B7-2 is: the forward primer PF7-2A is 5'-GCGGATCCGCTGCTCCTCTG-3' (SEQ ID NO: 5), and a BamHI site is introduced at the 5' end; the reverse primer PR7-2A is 5'-CCCGGGTTAAGGAATGTGGTCTGG -3' (SEQ ID NO: 6), a stop codon TAA and a SmaI site were introduced at the 3 end. The B7-1 primers are: the forward primer PF7-1A is 5'-GCGGATCC-3' (SEQ ID NO: 7), and a BamHI site is introduced at the 5' end; the reverse primer PR7-1A is 5'-CCCGGGTTA-3 '(SEQ ID NO: 8), a stop codon TAA and a SmaI site were introduced at the 3' end. Primers PF7-2A and PR7-2A, as well as PF7-1A and PR7-1A amplify the cDNAs encoding the 1-225aa and 1-208aa fragments of the extracellular region variable regions...

Embodiment 2

[0100] Example 2: Construction of a novel recombinant immunosuppressive toxin fusion protein B7-PE40KDEL expression vector

[0101] According to B7-2 225 , B7-1 208 and PE40 target gene sequence, designed to amplify B7-2 225 , B7-1 208 Forward and reverse primers PF7-2B and PR7-2B, PF7-1B and PR7-1B, and PF-PEA and PR-PEA of PE40. For fusion construction, make B7-2 225 , B7-1 208 and the PE40KDEL gene with a flexible linker (Gly 4 Ser) 4On this basis, the reverse primer PR-PEB was designed. The difference between PR-PEB and PR-PEA is that the 5' REDLK can be replaced by KDEL, and in primers PF7-2B and PF7 EcoRI and MunI restriction sites were introduced into -1B, a repeat sequence of primers PR7-2B and PR7-1B was included in the primer PF-PEA, and a SmaI restriction site and connecting peptide were introduced into the primer PR-PEA [(Gly 4 Ser) 4 ] coding sequence. See Table 1 for details.

[0102] Table 1. Construction of primer sequences containing the fusion gene...

Embodiment 3

[0127] Embodiment 3: Expression of recombinant toxin protein fusion gene B7-PE40KDEL

[0128] The plasmids pGEM-T-B7-2-PE40KDEL and pGEM-T-B7-1-PE40KDEL constructed in Example 2 were respectively used as templates, and PF7-2B or PF7-1B and PR-PEB were used as primers to amplify the target fragment. The 100ul volume PCR reaction system is: 100ngDNA template, 10× reaction buffer, 10pmol of upstream and downstream primers, 10mmol / l dNTP 10ul, 25mmol / l MgSO4 6ul, dimethyl sulfoxide 10ul, Taq DNA polymerase 2U, double distilled Make up the volume with water to 100ul. The PCR reaction conditions were: 98°C for 3min, cycle parameters: 94°C for 1min, 55°C for 1min, 72°C for 1.5min, after 25 cycles, extend at 72°C for 10min. The length fragments of B7-1-PE40KDEL DNA and B7-2-PE40KDEL amplified by PCR reaction were 1842bp and 1791bp, respectively. After the PCR reaction products were recovered, they were inserted into the pGEM-T vector respectively, and the about 1.8kb fragment was ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A novel immunosuppression fusion protein, its coding nucleic acid and its application are disclosed.

Description

field of invention [0001] The invention belongs to the fields of molecular biology, immunology and drug design. More specifically, the present invention relates to a novel immunosuppressive fusion protein, its encoding nucleic acid and its use. Background technique [0002] Allogeneic hematopoietic stem cell transplantation (HSCT) and solid organ transplantation have become one of the most effective methods to treat various malignant blood diseases, genetic diseases, severe radiation sickness and severe combined immunodeficiency and various organ failures so far. . Graft-versus-host disease (GVHD or GVHR) and host-versus-graft reaction (HVGD) are inevitable due to differences in donor-recipient histocompatibility complex (MHC) (and of course many other unknown factors) , which is one of the most important causes of allogeneic HSCT and organ transplantation failure. Therefore, GVHD and HVGD have become the biggest obstacles to clinical allogeneic HSCT and organ transplanta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C07H21/00C12N15/62C12N15/63C12N15/70C12P21/00A61K38/16A61P37/02A61P3/10A61P19/02A61P17/06A61P21/04
Inventor 奚永志袁志宏张惠丽关海容孔繁华
Owner AFFILIATED HOSPITAL CHINA ACADEMY OF MILITARY MEDICAL SCI